FDA - Food and Drug Administration

Targeted antibiotic gel helps 80% of pilot patients avoid foot amputation, Jerusalem trial finds

GentaGel’s biodegradable treatment releases antibiotics directly at infection sites for up to 60 days; the company is pursuing further trials and an FDA regulatory pathway.

Dr. Ariel Orbach (L), Co-Founder and CEO of GentaGel, Prof. Avi Domb (M), Inventor of GentaGel-LR Technology, and Eli Lerner (R), Co-founder and COO of GentaGel.
Menta "Steve" Wallace shows a bottle of daraxonrasib, Revolution Medicine?s pancreatic cancer drug, at his home in The Woodlands, Texas, U.S., May 29, 2026.

Revolution Medicines gets FDA approval for targeted pancreatic cancer drug

A close-up view of a large pile of green jalapeño peppers

What do we know about the multistate salmonella outbreak in the US? - explainer

The logo of US supplier Taylor Farms at the company's installations following the temporary closure announced by Taylor Farms, in Doctor Mora, Guanajuato state, Mexico, July 24, 2026.

Taylor Farms recalls salsa, guacamole over salmonella risk, weeks after cyclosporiasis concerns


Wait 3 days, then swab throat and nose when using antigen test, Health Ministry says

The Health Ministry published new recommendations on how to use the at-home kits, amid criticism for their lack of accuracy.

 Meuhedet Health care worker wearing protective gear takes swab samples from a woman, at Meuhedet coronavirus testing center in Jerusalem, January 6, 2022.

Controversial Alzheimer's drug administered for first time in Israel

This marks the first time that the drug has been used outside of the United States.

 Dr. Bergman, the first patient Jeremiah Kozari and Dr. Shiner.

Israeli firm SpliSense moves to clinical trials for cystic fibrosis treatment

"It will improve patients' lung function, reduce lung inflammation, enable them to breathe better, and go back to normal life."

 Treating Cystic Fibrosis (illustrative).

US FDA clears Pfizer's COVID-19 booster shot for 12- to 15-year-olds

The FDA said it reviewed published data and real-world evidence on the safety of booster doses provided by the Israeli Ministry of Health.

An illustrative photo of the Pfizer COVID-19 vaccine.

US authorizes German Firm's at-home COVID-19 test

The approval comes at a time when companies such as Walmart Inc, Walgreens Boots Alliance and CVS Health Corp have limited sales of at-home COVID-19 testing kits as demand surged.

Israeli receiving a COVID test at Meuhedet Health Maintenance Organization center in Jerusalem on August 11, 2021.

Roche's at home covid test kit gets emergency FDA approval

The test, which uses a anterior nasal swab sample, is 'able to produce accurate, reliable and quick results in as few as 20 minutes' for SARS-CoV-2 and all variants of concern.

A box of material for rapid COVID-19 antigenic tests made by Swiss drugmaker Roche is pictured at the University Hospital (CHUV) during the coronavirus disease (COVID-19) outbreak in Lausanne, Switzerland, November 13, 2020.

US FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds

All US adults are currently eligible for booster shots of the three authorized COVID-19 vaccines.

Signage is seen outside of FDA headquarters in White Oak, Maryland.

US FDA evaluating effectiveness of COVID-19 vaccines against Omicron

BioNTech and Pfizer's established COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant.

Signage is seen outside of FDA headquarters in White Oak, Maryland.

Israeli antibody treatment co. acquires four FDA-approved drugs

The combined 2021 annual global revenue from the four products is expected to be around $45 million. 

Kamada's factory in Beit Kama

UW researchers create lifesaving device that reverses opioid overdoses

Opioid overdoses have become a health crisis, with mortality increasing over the course of the COVID-19 pandemic, according to the study.

The drug Naloxone sits on a table during a free Opioid Overdose Prevention Training class provided by Lourdes Hospital in Binghamton, New York, US, April 5, 2018.